The First Affiliated Hospital, Zhejiang University School of Medicine — Hangzhou, Zhejiang

Public research footprint of The First Affiliated Hospital, Zhejiang University School of Medicine, compiled from the ClinicalTrials.gov public registry.

446

Registered studies

309

Active

193

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Glypican-3 (GPC3)-Positive Squamous Non-small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung · Non-small Cell Lung Cancer (NSCLC) · Relapsed/Refractory Follicular Lymphoma

Recently updated registry entries

NCT07227597 — A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People… (Recruiting)
NCT06158841 — Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard… (Recruiting)
NCT06841354 — A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The First Affiliated Hospital, Zhejiang University School of Medicine?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.